Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities
Rhea-AI Summary
Inspire Veterinary Partners (NASDAQ:IVP) has secured a financing agreement for up to $10 million through a convertible preferred stock transaction at $1.00 per share. The deal structure includes $6 million in initial funding through cash and securities, with potential additional closings of up to $4 million.
The company plans to utilize the proceeds for working capital, veterinary practice acquisitions, addressing Nasdaq shareholders' equity requirements, and extending operational runway. CEO Kimball Carr highlighted the company's execution of its growth strategy, noting recent acquisitions and record clinical hiring in 2025.
Positive
- Secured up to $10 million in new financing to support growth
- Initial funding of $6 million secured through cash and securities
- Funds will help address Nasdaq compliance issues
- Company reports successful acquisitions and record clinical hiring
Negative
- Existing Nasdaq deficiencies in Shareholders Equity requiring attention
- Need for additional capital to maintain operations indicates cash constraints
- Potential dilution for existing shareholders at $1.00 per share
News Market Reaction
On the day this news was published, IVP declined 7.62%, reflecting a notable negative market reaction. Argus tracked a peak move of +25.7% during that session. Argus tracked a trough of -9.2% from its starting point during tracking. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $331K from the company's valuation, bringing the market cap to $4M at that time.
Data tracked by StockTitan Argus on the day of publication.
VIRGINIA BEACH, VA / ACCESS Newswire / August 4, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a securities purchase agreement for the issuance and sale of securities under a new convertible preferred stock transaction. The consideration, consisting of a combination of cash and transferred securities, was valued at
The gross proceeds to the Company from the offering are expected to be up to
"As communicated earlier in 2025, the team at IVP is executing on our growth strategy and this offering helps to facilitate our objectives," said President, Chairman and CEO, Kimball Carr, "With new acquisitions onboarded and record clinical hiring this year, I could not be prouder of our team for the continued progress being made across all departments within IVP."
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Inspire Veterinary Partners, Inc.
Inspire Veterinary Partners is an owner and provider of pet health care services throughout the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care. For more information, please visit: www.inspirevet.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, statements by the Company relating to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds from the offering, receipt of Stockholder Approval as well as risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.
Investor Contact
CoreIR
Matt Blazei
516-386-0430
mattb@coreir.com
Press Contact
CORE IR
Matthew Cossel
pr@coreir.com
General Inquires
Morgan Wood
Mwood@inspirevet.com
SOURCE: INSPIRE VETERINARY PARTNERS, INC.
View the original press release on ACCESS Newswire
FAQ
What is the size and price of Inspire Veterinary Partners (IVP) new financing deal?
How will IVP use the proceeds from the $10M financing?
What are the terms of IVP's initial funding in the financing agreement?
Why does Inspire Veterinary Partners need this financing?
What recent progress has IVP reported in their business operations?
